Cara Therapeutics, Inc. (CARA)

NASDAQ: CARA · IEX Real-Time Price · USD

0.278

+0.015 (5.67%)

At close: Jul 2, 2024, 4:00 PM

0.285

+0.007 (2.55%)

After-hours: Jul 2, 2024, 7:52 PM EDT

Cara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Net Income	-118.51	-85.47	-88.44	8.41	-106.37	Upgrade
Depreciation & Amortization	2.33	1.67	1.55	1.02	0.8	Upgrade
Share-Based Compensation	13.73	17.73	20.79	14.84	12.57	Upgrade
Other Operating Activities	10.37	-12.66	6.02	-29.75	-16.22	Upgrade
Operating Cash Flow	-92.08	-78.73	-60.09	-5.49	-109.23	Upgrade
Capital Expenditures	-2.38	-0.04	0.03	-0.35	-0.02	Upgrade
Change in Investments	45.84	128.75	-4.78	-19.93	-30.5	Upgrade
Investing Cash Flow	43.46	128.71	-4.75	-20.28	-30.52	Upgrade
Share Issuance / Repurchase	1.68	0.31	46.61	39.14	142.6	Upgrade
Debt Issued / Paid	36.47	0	0	0	0	Upgrade
Financing Cash Flow	38.15	0.31	46.61	39.14	142.6	Upgrade
Net Cash Flow	-10.47	50.29	-18.23	13.38	2.86	Upgrade
Free Cash Flow	-94.45	-78.77	-60.06	-5.84	-109.24	Upgrade
Free Cash Flow Margin	-450.46%	-188.15%	-260.80%	-4.32%	-549.35%	Upgrade
Free Cash Flow Per Share	-1.74	-1.47	-1.18	-0.12	-2.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).